XyloCor Therapeutics
Pre-clinicalXyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.
Founded
2016
Focus
RNA & Gene Therapy
About
XyloCor Therapeutics is focused on improving the lives of people with cardiovascular disease through our commitment to advancing the science of gene therapy.
Funding History
2Total raised: $111M
Series B$80MNovo HoldingsJul 15, 2022
Series A$31MSofinnova InvestmentsOct 15, 2020
Company Info
TypePrivate
Founded2016
LocationPhiladelphia, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile